Please login to the form below

Not currently logged in
Email:
Password:

AveXis

This page shows the latest AveXis news and features for those working in and with pharma, biotech and healthcare.

Novartis says data backs safety of on-hold intrathecal Zolgensma

Novartis says data backs safety of on-hold intrathecal Zolgensma

The approved version can be used in children with all types of SMA, but Novartis’ AveXis’ unit is trialling intrathecal administration – injection directly into the spinal canal – to try to expand ... For milder forms of the disease that occur

Latest news

More from news
Approximately 4 fully matching, plus 21 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Collected Group

Collected Group is a forward thinking healthcare communication company that supports biopharma and diagnostic companies to engage in more lasting...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....